WO2023041802 - IN VITRO CELL CO-CULTURES OF NEURONAL CELLS, ASTROCYTES, AND OLIGODENDROCYTES
National phase entry:
Publication Number
WO/2023/041802
Publication Date
23.03.2023
International Application No.
PCT/EP2022/076103
International Filing Date
20.09.2022
Title **
[English]
IN VITRO CELL CO-CULTURES OF NEURONAL CELLS, ASTROCYTES, AND OLIGODENDROCYTES
[French]
CO-CULTURES CELLULAIRES IN VITRO DE CELLULES NEURONALES, D'ASTROCYTES ET D'OLIGODENDROCYTES
Applicants **
KATHOLIEKE UNIVERSITEIT LEUVEN
KU Leuven R&D
Waaistraat 6 - box 5105
3000 Leuven, BE
Inventors
AHUJA, Karan
Brabanconnestraat 103
3000 Leuven, BE
FURTADO MADEIRO DA COSTA, Rodrigo
Edouard Remyvest 46 bus 201
3000 Leuven, BE
VERFAILLIE, Cathérine
Alfons Smetsplein 3 - bus 3D-202
3000 Leuven, BE
Priority Data
21197737.6
20.09.2021
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1800 | |
| EPO | Filing, Examination | 8640 | |
| Japan | Filing | 591 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 3910 |
Total: 15516 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The invention relates to an in vitro cell culture comprising neuronal cells derived from iPSC, optionally with an NGN2 transgene, astrocytes derived from iPSC with a SOX9 transgene, and oligodendrocytes derived from iPSC with a SOX10 transgene.[French]
L'invention concerne une culture cellulaire in vitro comprenant des cellules neuronales dérivées de iPSC, facultativement avec un transgène NGN2, des astrocytes dérivés de iPSC avec un transgène SOX9, et des oligodendrocytes dérivés de iPSC avec un transgène SOX10.